The present invention provides novel AKT inhibitor compounds of formula I wherein L"~2 a=l or 2 X and Y is each independently selected from C, 0 or N. X and R2 may be directly attached or attached via a linking group L which may be selected from an Oxygen atom or a CO group Z is H or Alkyl R1 = H or wherein ...

The present invention relates to novel steroidal compounds of formula (I) process for preparation of the same and composition comprising these compounds.

The present invention provides novel analogues of epicatechin and related polyphenols, their variously functionalized derivatives, process for preparation of the same, composition comprising these compounds and their method of use.

The  present  invention  provides  carbamoylated  compounds  of 2-(nicotinamido)ethyl  nitrate  2-(nicotinamido)ethyl nitrate and the process for preparing said compounds.

A process for synthesis of enatiomerically pure or enatiomerically enriched or racemic mixture of (+and/or ) epicatechin and its intermediates comprising the steps of: (i) obtaining penta protected quercetin; (ii) reducing the penta protected quercetin obtained from step (i); (iii) optionally deprotecting the compou...

The present invention provides novel compounds of 11ß hydroxy steroids and compositions and their application as pharmaceuticals for preventing or reversing injury to mitochondria for treating or preventing diseases relating to mitochondrial dysfunction or depletion and for inducing regeneration or restructuring of ...

The present invention pertains to the enhanced activity of (+) epicatechin over (-) epicatechin. The present invention is related to novel analogs of (+) epicatechin of the formula (I), which enhances the pharmacokinetics and therefore the pharmacodynamics of (+) epicatechin. The present invention is related to anal...

The present invention provides novel compounds with improved solubility and altered pharmacokinetic properties. The compounds of the present invention may be represented by Formula (I).

The present invention discloses a novel, stable and synergistic combination of epicatechin with anti-cancer compounds. The present invention also discloses a composition comprising the novel combination of epicatechin with anti-cancer compounds along with other pharmaceutically acceptable excipients. ...

The present invention relates to novel compounds of formula (1): The present invention also discloses compounds of formula (1) along with other pharmaceutical acceptable excipients and use of the compounds as anti tubercular agents.